AmSurg receives ‘buy’ rating — 5 notes

Citigroup analysts gave AmSurg a “buy” rating, according to Baseball News Source.

Advertisement

Here are five notes:

1. On June 14, Wells Fargo gave AmSurg shares a “market perform” rating.

2. AmSurg’s 50-day moving average is $65.74.

3. The 200-day moving average is $73.68.

4. AmSurg has a 52-week low of $58.37 and a 52-week high of $87.29.

5. The company’s market cap. is $3.48 billion.

More articles on surgery centers:
Conifer Health to handle value-based care services for Canopy Health in CA: 3 things to know
Zacks gives SCA ‘sell’ rating — 5 notes
Dr. Craig Amshel opens surgery center to expand healthcare access to Floridians — 4 key points

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.